New perspectives in the treatment of metastatic renal cell carcinoma

Publication year: 2011 Source: Critical Reviews in Oncology/Hematology, Available online 17 November 2011 Jérôme Barrière, Benjamin Hoch, Jean-Marc Ferrero Since 2007, the advent of so-called “targeted” therapy has revolutionized the management of renal cell carcinoma (RCC), replacing interferon or interleukin-2 immunotherapy.

Publication year: 2011 Source: Critical Reviews in Oncology/Hematology, Available online 17 November 2011 Jérôme Barrière, Benjamin Hoch, Jean-Marc Ferrero Since 2007, the advent of so-called “targeted” therapy has revolutionized the management of renal cell carcinoma (RCC), replacing interferon or interleukin-2 immunotherapy.

Originally posted here:
New perspectives in the treatment of metastatic renal cell carcinoma